Radioiodinated metaiodobenzylguanidine in the diagnosis and therapy of carcinoid tumors.


Carcinoid tumors account for less than 1% of all malignancies and the majority arises in the gastrointestinal system. These tumors are slow-growing compared with adenocarcinomas and they differ from the other neuroendocrine malignancies by their protean clinical presentation. Carcinoid tumors were previously considered indolent, but they can manifest… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.